The Veterans Health Administration piloted patient-centered care (PCC) innovations beginning in 2010 to improve patient and provider experience and environment in ambulatory care. We use secondary data to look at longitudinal trends, evaluate system redesign, and identify areas for further quality improvement. Methods: This was a retrospective, observational study using existing secondary data from multiple US Department of Veteran Affairs sources to evaluate changes in veteran and facility outcomes associated with PCC innovations at 2 innovation and matched comparison sites between FY 2008-2010 (pre-PCC innovations) and FY 2011. Outcomes included access to primary care providers (PCPs); primary, specialty, and emergency care use; and clinical indicators for chronic disease. Results: Longitudinal trends revealed a different story at each site. One site demonstrated better PCP access, decrease in emergency and primary care use, increase in specialty care use, and improvement in diabetic glucose control. The other site demonstrated a decrease in PCP access and primary care use, no change in specialty care use, and an increase in diastolic blood pressure in relation to the comparison site. Conclusion: Secondary data analysis can reveal longitudinal trends associated with system changes, thereby informing program evaluation and identifying opportunities for quality improvement.
it requires a multidimensional effort focusing on improving quality, safety, and patient perceived and actual value of health care. 4 Many research studies support evidence-based clinical practices that demonstrate better quality care in controlled research studies or in narrowly defined descriptive studies. [5] [6] [7] Translating this evidence into practice has been challenging. There are many variables affecting change within each institution, making it difficult to create a single clear prescriptive implementation plan. Each institution has its own culture, staffing patterns, and patient mix--one size does not fit all. Success in translating evidence into practice requires taking into account all of these variables-or the context of the organization as a whole-to achieve innovation goals. 8 Secondary data, or data collected for other reasons, provide an opportunity to look at quality indicators within an institution over time to identify the impacts of quality innovations independent of other organizational variables. 9, 10 As the largest health system in the country with a long-standing electronic health record system and data warehouse comprising data sourced from hundreds of US Department of Veteran Affairs (VA) clinical sites, the VA provides an opportunity to measure the effect of emerging health care delivery models across the country.
Beginning in 2010, the VA adopted the Patient Aligned Care Team (PACT) model of care, which is adapted from the patient-centered medical home.
to guide transformation toward patient-centered care (PCC). This office supported the development and implementation of targeted PCC innovations at 4 pilot VA medical centers across the country focusing on fostering healing environments and building dynamic partnerships between patient, family, health provider, and other health team members and employees. These pilot sites were called Centers of Innovation (COIs). Each COI site implemented multiple, but sometimes different, innovations based on site need. PCC innovations were aimed at improving patient care and included offerings aimed at improving the employee experience. Examples of the diverse PCC innovations for patients included health coaching, personalized health planning, shared decision-making initiatives, relaxation and new complementary/alternative medicine offerings (comfort massage, movement classes, breathing awareness); healing arts (aroma therapy, music, and art therapy); and animal/pet therapy. Access to care improvements included same-day appointments, afterhours availability, expanded visitor policy for inpatients, and valet parking. Technology updates included immediate customer feedback (called Truthpoint), GetWell Network Patient Life System (http://getwellnetwork. com), and medication-dispensing kiosks. Environment of care updates included patient-centered interior redesign, facility wayfinding and updated signage, and grounds improvements (eg, walking trails and gardens). Other innovations were available for health providers such as hands-free communication and employee training in holistic care, mindfulness, integrative medicine, and narrative medicine. Employees participated in PCC retreats and onboarding seminars. Wellness modalities targeting employees were offered, including massage chairs, wellness programs, and relaxation spaces.
As part of a national evaluation plan, teams of evaluators at the VA Center for Evaluation of Practices and Experiences of Patient Centered Care, based at the Edward J. Hines VA Hospital, evaluated PCC innovations at the COIs. The evaluation team worked with individuals at the COIs (including PCC coordinators, center leaders, and team members) to collect information to understand implementation of PCC innovations. Evaluators also assessed innovation-related patient and provider outcomes related to PCC using the wealth of VA secondary data sources. Although each COI implemented different innovations, the overall goal was to improve patient and provider experience and environment of care. The following presents the overall method used in evaluating PCC innovations, as well as findings of the effects of PCC innovations, at 2 of the 4 pilot sites. These 2 sites were chosen because their findings tell compelling site-specific stories. Each story helps us better understand the impact of PCC innovations on care continuity and ambulatory care utilization and opportunities for quality improvement.
REVIEW OF LITERATURE
PCC is designed to provide care that facilitates a collaborative relationship among providers and to empower patients to take ownership and responsibility for their own health. This begins with establishing a trusting, consistent relationship. 12 Therefore, PCC innovations are designed not only to eliminate barriers to care but also to promote provider practices that encourage patient engagement in accessing primary care services for preventive, coordinated, and self-care, as well as promote coordination and continuity of care to best meet the needs of the patient. 13 Through shared decision making and mutual collaboration, patients will receive care in the most appropriate setting. By focusing on preventing complications and aligning care plans to patient personal health goals, providers are available to address issues early and avoid unnecessary care in acute care settings. 12, 14 Convenient primary care access with a personal primary care provider (PCP), a key characteristic of PCC, is associated with lower mortality and higher quality, 15 particularly for low-income populations, 16 older adults, 17, 18 and vulnerable populations. 19 Research also suggests that PCC is associated with better clinical indicators, particularly for patients with chronic illness. 20 Access to a PCP allows for regular monitoring, better chronic care management, and individualized patient teaching. 15 20 We hypothesized that PCC innovations will lead to better access to PCPs and, subsequently, more primary care use, less specialty care use, and fewer emergency department (ED) visits. Ultimately, in the long term, this system transformation is expected to improve veteran clinical indicators for chronic disease.
STUDY DESIGN AND METHODS
This was a retrospective, observational study using existing secondary data from multiple VA sources to examine changes in veteran and facility outcomes at 4 geographically dispersed COI sites between FY 2008-2010 (pre-PCC innovations) and FY 2011-2012 (post-PCC innovations). The following presents detailed analysis of 2 of the 4 sites to both demonstrate how secondary data tells a compelling story and ensure anonymity of the sites. We compared change over time within each respective COI site.
This evaluation employed a matched comparison group design. For each COI site, we selected a non-COI site located within the same geographic area and VA network with similar patient population acuity and system infrastructure. We then compared outcomes at COI sites with those at the matched comparison sites for each COI comparison site pair. The use of a matched comparison helped distinguish effects of innovations on outcomes from effects of unrelated events or geographic contextual factors that may have impacted outcomes for both innovation and comparison sites. This project was conducted as part of a quality improvement project (classified as such by the VA Central institutional review board) to evaluate and understand the effect of PCC innovations on secondary data quality improvement indicators.
DATA SOURCES
Multiple data sources were used to examine facilitylevel and individual (veteran)-level analyses. The PACT Compass is a monthly administrative report for each facility. These data provide a "facility" level of data aggregation summarizing inpatient and outpatient quality metrics per month. The outpatient metrics were used for this study because innovations were designed to affect ambulatory care. The PACT initiative began in 2010, so 2010-2012 data were used for this study.
Several data sources were used to measure individual veteran trends: the Primary Care Management Module (PCMM) to identify patients who have an assigned PCP; the Medical SAS Outpatient data sets for demographics, health conditions, and health care utilization information 21, 22 ; the Managerial Cost Accounting Laboratory Results National Data Extract data sets for low-density lipids, high-density lipids, and glycated hemoglobin clinical indicators; the VA Corporate Data Warehouse for blood pressure measures, Planning Systems Support Group data for distance to VA facility; and the Assistant Deputy Undersecretary for Health Fiscal Year-End Enrollment File to identify veterans' enrollment information.
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SAMPLE
The sample used for facility-level trends in the PACT Compass included all patients who were enrolled in the PCMM and used services that month at the respective outpatient site. The sample used for individual patient-level trends in health care utilization and clinical indicators included all veterans who were enrolled in the PCMM and used health care services at least once in FY 2008. Following this cohort of patients with FY 2008 utilization provided a consistent comparison from year to year. Subsamples included cohorts of patients with DM, hypertension, and coronary artery disease (CAD). Specific data extraction rules and inclusion and exclusion criteria are listed in Table 1 for each hypothesis. This data extraction strategy focused on identifying only those patients who regularly used the outpatient site for primary care and excluded patients who only used that site for consultation or emergency services.
VARIABLES/OUTCOME MEASURES
The study evaluated indicators associated with coordination and continuity of care, as shown in Table 1 . We anticipated that administrative and provider behaviors to improve patient access would change first, leading to veterans choosing a more appropriate site of care (eg, primary care over ED), which ultimately would affect veteran clinical indicators. Table 1 presents the hypotheses, variable definitions, data source(s), and data extraction rules for selected short-, intermediate-, and long-term outcomes. Outcomes are defined as changes in knowledge, skills, attitudes, or functions that may relate to specific activities and are classified on the basis of time from the activity. Short-term outcomes should be attainable within 1 to 3 years, whereas longer-term outcomes should be achievable within a 4-to 6-year time frame.
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Short-term outcomes: Provider access
Data measuring patients' access to their PCP were extracted from the PACT Compass. This measure provided a facility-level snapshot of monthly fluctuations in patient access for all PCP-assigned patients who had been seen in the outpatient setting during 2010-2012. 
Intermediate-term outcomes: Patient utilization behavior
We examined 3 intermediate outcomes that included emergency care use, primary care use, and specialty care use. Emergency services use was measured per facility as the ED to primary care (PC) ratio and was obtained from the PACT Compass monthly administrative reports. This variable represents a facility-level snapshot of emergency service use. Patient-level measures of veterans' primary and specialty care use were extracted from the electronic health record and the PCMM for the years 2008-2012. 27 Using a combination of CPT (Current Procedural Terminology) codes and clinic stop codes, we classified ambulatory care visits into primary, specialty, diagnostic service, and mental health visits. 28 A clinic stop code is the designation by which the Veterans Health Administration defines outpatient clinical work units for costing purposes. 29 We modified the Burgess et al method 28 in that we allowed multiple visits on the same day, specifically we counted primary care and specialty care visits and multiple specialty visits on the same day. For example, a visit to both a cardiologist and an endocrinologist on the same day would constitute 2 specialty care visits.
Long-term outcomes: Patient health indicators
We used the clinical data extracts from the electronic health record and stored in the VA Corporate Data Warehouse and National Data Extract data sets to measure the proportion of patients with an elevated level of HbA 1c (≥9%) as an indicator of poor glucose management among patients with diabetes. 30 We also measured the proportion of patients with CAD who had elevated low-density lipoprotein cholesterol (LDL-C ≥130 mg/dL), indicating poor disease control, and highdensity lipoprotein cholesterol (HDL-C ≥40 mg/dL), indicating good disease control. Finally, we measured the proportion of patients with a diagnosis of hypertension with diastolic blood pressure 90 mm Hg or more and systolic blood pressure 140 mm Hg or more, indicating poor disease control. These data were aggregated at the veteran level following a cohort of veterans from 2008 to 2012. 
Covariates
Patient demographic, comorbidities, and health care encounter information were extracted from VA outpatient data and VA enrollment files to control for covariates that may potentially confound our results. 21, 22 Comorbidities were identified on the basis of the Elixhauser algorithm. 25 Particularly for short-term outcomes, we hypothesized that over time there would be a significant change during the first-year postinnovation, with a continual improving trend in subsequent years. We hoped that intermediate-and long-term outcomes demonstrated improving trends over time. Because the PACT Compass report began in 2010, patient access to PCP and use of ED was limited to January 2010 to December 2013. Use of primary and specialty care services was evaluated pre-(2008-2009) and post-(2010-2012) PCC innovation implementation. These longitudinal curves "tell the story" before, during, and after the innovations.
DATA EXTRACTION AND CLEANING
The data extraction and cleaning process is critical in maximizing accuracy and fidelity of data, particularly when using secondary data sets. 9 We recorded data extraction decisions and procedures during weekly team meetings, which are summarized in Table 1.   9 Once data were extracted, several programming verification methods were used. 9 Each data set was evaluated for plausibility for gross error by comparing the data set with national statistics. If errors were found, data extraction programming was checked for accuracy. If programming was accurate and there were gross differences per site, we then evaluated systematic historical, cultural, or administrative differences that could affect data entry. If these errors existed, we eliminated that time period from the analysis or disregarded that time period when interpreting findings. There was no evidence of systematic error for the indicators and sites presented in these outcomes.
DATA ANALYSIS
Percentage of primary care visits with PCP and emergency services use
PACT Compass data were analyzed using an interrupted time series with segmented regression, with autocorrelation appropriately tested and controlled. 31 We used the locally weighted scatterplot smoothing (LOWESS) method to graphically represent trends over time for COIs and matched comparison sites. We tested for differences in slope between COI and matched sites from 2010 to 2013.
Primary care and specialty care use and clinical indicators
Sample patients were followed for 5 years (ie, 2008-2012). We aggregated the outpatient clinical data into patient-year records (1 record per patient per year) and analyzed these longitudinal data using logistic regression while appropriately controlling for the repeated nature of the data (eg, generalizing estimating equations with random intercepts). All analyses were adjusted for patient characteristics that may potentially confound the results to specifically evaluate veteranlevel changes, as described in Table 1 . Primary and specialty care use is presented as percent change in outcome postinnovation from 2010 to 2012.
FINDINGS
Site 1 had a total of 61 PCC innovations in place, with 16% of the innovations fully or partially implemented, and site 2 had a total of 93 PCC innovations in place, with 30% of innovations fully or partially implemented as part of PCC initiatives. The following presents the findings for 2 COI/matched comparison sites as examples of how secondary data can tell the story of PCC innovation impact over time. Findings are presented by COI and matched site pairs and are summarized in Table 2 . Figure 1B , site 1-COI showed a statistically significant decreasing trend in ED to PC ratio postinnovation (P < .001), whereas site 1-matched showed a statistically significant increasing trend over the same time period (P < .001), with a significant difference in slopes (P < .001).
Site 1 findings for veteran cohort of primary and specialty care utilization
Innovations related to patient use of primary care versus specialty care included moving specialty care services closer to the patient. Innovations in primary care practices included shared decision making and narrative medicine, and innovations in primary care environment included decreasing noise and adding facility wayfinding signs, comfortable waiting rooms, concierge desk/greeters, military display cases, and Internet access/WiFi hot spots. This veteran cohort demonstrated a significant decrease in primary care use at site 1-COI from 2010 to 012 (−4% change; P < .001) but significant increase (8%; P < .001) in specialty care use. Site 1-matched, in contrast, experienced no significant change in primary care use (0%; P = .617) over the 3 years but demonstrated a significant increase in specialty care use (25%; P < .001) during that same time period.
Site 1 findings in clinical indicators
Several innovations were designed to facilitate patient access to clinical information and promote chronic care management. Examples included accessible laboratory results, open access to information, nutrition/healthy cooking classes, and an automated pharmacy-dispensing center. For patients with a diagnosis of DM, site 1-COI demonstrated no significant change in the percentage of patients with an HbA 1c level of more than 9% from 2010 to 012 (odds ratio [OR] = 1.07; P = .331), in contrast to a significant increase in patients with DM who had an HbA 1c level of more than 9% at the matched site (OR = 1.66, P < .001) during the same time period. For veterans with a diagnosis of CAD, site 1-COI demonstrated no significant change in the number of CAD patients with LDL of 30 mg/dL or more from 2010 to 2012 (OR = 1.00, P = .990) and a significant decrease in the number of CAD patients with high LDL levels at the matched site (OR = 0.85, P < .001). For patients with a diagnosis of hypertension, site 1-COI demonstrated that the number of those with poorly controlled systolic blood pressure (≥130 mm Hg) increased (OR = 1.21, P < .001), and there was no significant change in the number of patients with diastolic blood pressure of 90 mm Hg or more (OR = 1.14, P = .091), whereas the matched site demonstrated no significant changes in systolic (OR = 1.04, P = .286) or diastolic blood pressure control (OR = 1.07, P = .150).
Site 2 Site 2 findings for facility level continuity of care
Similar to site 1, site 2 innovations also included offering or enhancing the availability of same-day appointments and after-hours access. As shown in Figure 2A , site 2-COI began with a higher percentage of veterans seeing their PCP in primary care and a lower ED to PC ratio in 2010 in comparison with site 2-matched. Site 2-COI demonstrated a statistically significant decreasing trend in proportion of veterans who saw their PCP from 2010 to 2012 (P < .001), whereas site 2-matched demonstrated a statistically significant increasing trend over the same time period (P < .001), with a statistically significant difference in slopes (P < .001). As shown in Figure 2B , site 2-COI showed a statistically significant increasing trend in ED to PC ratio postinnovation (P < .001) whereas site 2-matched showed a statistically significant decreasing trend over the same time period (P < .001), with a significant difference in slopes (P < .001).
Site 2 findings for veteran cohort of primary and specialty care utilization
Innovations related to patient use of primary care versus specialty care included moving specialty care services closer to the patient. Innovations in primary care practices, including transformative nurse education, included shared decision making, health coaching, and narrative medicine. Innovations in the primary care environment included decreasing noise, providing more comfortable waiting rooms, pagers in waiting areas for patient/families, concierge desk/greeters, valet parking, and hospital interior artwork. Primary care use at site 2-COI significantly decreased from 2010 to 2012 (−22%; P < .001), and there was no significant change in specialty care use (−2%; P = .288). Patients at site 2-matched during that same time period experienced a significant increase in primary care use (2%; P = .007) and no significant change in specialty care use (1%; P = .354). For veterans with CAD, both sites demonstrated a decrease in high LDL-C (OR = 0.58, P < .001; OR = 0.75, P < .001, respectively) postinnovation and demonstrated an increase in high HDL-C (OR = 1.67, P < .001; OR = 2.88; P < .001). Site 2-COI demonstrated a significant increase in the number of patients with elevated systolic blood pressures (OR = 1.22, P < .001) and no significant change in diastolic blood pressures (OR = 0.89, P = .263). Site 2-matched demonstrated an increase in the number of patients with both elevated systolic and diastolic blood pressures (OR = 1.22, P < .001; OR = 1.43, P < .001, respectively).
Site 2 findings in clinical indicators
DISCUSSION
As with any system redesign, changes occur over time, and it also takes time for work flow and patient flow to adapt to the change. Evaluating each site using secondary data provides an opportunity to study contextualized innovation implementation over time.
Site 1
PCP access improved and ED use declined relative to primary care use in site 1-COI. We could not determine whether the former led to the latter. However, on the basis of the literature, the decrease in primary care use and increase in specialty care use by the veteran cohort were unexpected. Our findings suggest that fewer veterans are using primary care and the movement of specialty care closer to patients may have affected the increased use of specialty care. An initial evaluation may indicate that more outreach is needed to encourage veterans to access primary care, particularly for PCMM patients. However, when looking at clinical indicators, the story may unfold differently in relation to the increase in specialty care use. With the DM patient population, this stability in PCC site 1-COI was a significant improvement in relation to the matched comparison for site 1. Specialty care use continued to rise postinnovation at both COI and matched sites. One possible explanation is that veterans with chronic conditions are managed in specialty practices; in this case, the diabetes clinic, which may have led to better longterm clinical indicators. Therefore, the increasing use of specialty care may also be due to the increase in chronic care management.
Site 2
Site 2-COI demonstrated a decreasing trend of primary care visits with their PCP; these findings were unexpected. Without meeting this short-term outcome, it would be difficult to positively affect the intermediate outcomes. This appears to be the case in that site 2-COI demonstrated an increasing trend of ED to primary care visits, a decreasing trend in primary care use, and no significant change in specialty care use. There is also no clear evidence that the long-term outcomes were positively affected. There was little difference in clinical indicators between the COI and matched comparison sites, with poor diabetic and systolic blood pressure clinical indicators but better CAD clinical indicators. It is possible that these differences may be due to PACT implementation, rather than COI innovations, since there is little difference between COI and matched comparison sites on these outcomes. However, patients at the COI site demonstrated no significant change in diastolic blood pressure postinnovation whereas the patients at the matched site demonstrated a significant increase in diastolic blood pressure. It is possible that the innovations targeting stress reduction may have affected blood pressure. 32, 33 However, as we have learned through recent publications on PCMM, long-term outcomes may require more time to evaluate conclusively.
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CONCLUSION
Each site story is different, as each site has its own history, organizational culture, staffing patterns, management strategies, and the number and type of PCC innovations. Site 1-COI demonstrated improved PCP access, which lead to more appropriate patient health care utilization and improvement in DM clinical indicators. Given that PACT was implemented simultaneously, it is possible that at site 1-COI, the PCC innovations may have potentiated the PACT effect.
Site 2 did not demonstrate expected changes. PCP access decreased, with higher emergency service use. Additional attention is needed to determine why the short-term outcome was not met. Without meeting this outcome, it may be difficult to meet the intermediateand long-term outcomes.
As with all secondary data studies, our study may have limitations in the accuracy of patient identification using ICD-9 (International Classification of Diseases, Ninth Revision) codes and in controlling for potential confounding variables from other observable and unobservable factors. Causal inferences based on our data should be made carefully if at all. The VA is unique in that it has a centralized national data repository that allows for national comparative studies. This study not only provides a detailed description in using secondary data for evaluation but also demonstrates how using multiple data sources can inform an evaluation by looking at longitudinal trends within the site and compared with a geographically similar site. Future steps should include sharing these findings with their respective sites to further interpret these findings within the context of the specific organization and to develop a targeted individualized quality improvement plan.
